IN-1233, an ALK-5 inhibitor: prevention of granulation tissue formation after bare metallic stent placement in a rat urethral model.
Kim
Jin Hyoung
JH
Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Poongnap-2 dong, Songpa-gu, Seoul, Republic of Korea.
Song
Ho-Young
HY
Park
Jung-Hoon
JH
Yoon
Hyun-Jung
HJ
Park
Hyung Gyu
HG
Kim
Dae-Kee
DK
D000818:Animals; D001549:Benzamides / Q000494:pharmacology*; D006097:Granulation Tissue / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000473:pathology*; D006965:Hyperplasia; D008297:Male; D008670:Metals; D011804:Quinolines / Q000494:pharmacology*; D011859:Radiography; D051381:Rats; D017207:Rats, Sprague-Dawley; D018709:Statistics, Nonparametric; D015607:Stents / Q000009:adverse effects; D014521:Urethra / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000473:pathology*
C538835:3-((4-(6-methylpyridin-2-yl)-5-(quinolin-6-yl)-1H-imidazol-2-yl)methyl)benzamide; D001549:Benzamides; D008670:Metals; D011804:Quinolines